Flexible Capital Structures
We focus on value-based care models, advanced diagnostics, digital therapeutics, and specialised manufacturing, backing companies at the intersection of regulatory momentum, clinical need, and platform scalability.
At DWM, we invest in healthcare businesses transforming care delivery, access, and outcomes. From specialised manufacturing and diagnostics to digital health and platform care, we back operators addressing long-term inefficiencies in cost, regulation, and scalability, across both developed and emerging markets.
We focus on value-based care models, advanced diagnostics, digital therapeutics, and specialised manufacturing, backing companies at the intersection of regulatory momentum, clinical need, and platform scalability.
We deploy capital across growth equity, structured investments, and strategic roll-ups, with a flexible approach aligned to sector cycles and enterprise readiness. We offer deep partnership on clinical strategy, product-market fit, and IP commercialisation, bringing operational depth, domain expertise, and long-term alignment to every investment.
We focus on IP-rich, defensible technologies, from quantum systems and advanced AI to cybersecurity and automation, while working closely with founders, research institutions, and innovation corridors to scale breakthrough ideas.
We back technologies that sit at the intersection of innovation and national interest, dual-use AI, defense IT, cyber infrastructure, and advanced manufacturing. Our approach prioritizes resilience, security, and sovereignty, aligning capital with both long-term economic value and strategic relevance.
Your go-to source for the latest stories and deeper understanding, all in one place.